Biohaven Pharmaceutical CEO and Key Executive Team

• Kimberly Gentile

  Senior Vice President, Clinical Operations
• Matthew Buten

  Chief Financial Officer
• Gregory H. Bailey

  Director
• John W. Childs

  Director
• John Donnie McGrath

  Chief of Corporate Strategy and Business Development
• Julia P. Gregory

  Director
• Michael T. Heffernan

  Director
• Marianne Frost

  Senior Vice President, Regulatory Affairs
• Robert J. Hugin

  Director
• John Tilton

  Chief Commercial Officer
• Kishen Mehta

  Director
• Beth Morris

  Vice President, Clinical Operations
• Anthony Gentile

  Senior Director, Clinical Operations & Program Finance
• Chris Jensena

  Director, Medical Affairs
• George Clark

  Vice President, Chief Accounting Officer
• Gilbert L'Italien

  Senior Vice President, GHEOR & Epidemiology
• Elyse Stock

  Chief Medical Officer
• Andrea Ivans

  Director, Clinical Operations
• Richard Bertz

  Vice President, Clinical Pharmacology and Pharmacometrics
• Melissa Beiner

  Director, Research & Development
• Amy O'Donnell

  Vice President, Head of Pharmacovigilance
• David Stock

  Vice President, Biostatistics
• Stephen Kaplita

  Senior Director, Biostatistics
• Gene Dubowchik

  Senior Vice President, Molecular Technologies
• Lisa Kamen

  Senior Director, Clinical Operations
• Jon Blaskovich

  Director, Information Technology
• Lisa Stocking

  Director, Regulatory Affairs & Operations
• Debora Robertson

  Senior Director, Clinical Supply Management
• Meghan Lovegren

  Director, Clinical Operations
• Victoria Wirtz

  Senior Director, Biostatistics
• Susan Durham

  Senior Director, Clinical Operations

Source: biohavenpharma.com, biohavenpharma.com